Navigation Links
Breast Cancer Drug Not Tied to Cognitive Decline: Study
Date:9/2/2008

Researchers say finding is 'good news' for postmenopausal women taking anastrozole

TUESDAY, Sept. 2 (HealthDay News) -- Contrary to previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found.

Anastrozole has been shown to be superior to tamoxifen in preventing breast cancer recurrence in postmenopausal women. But some "cross-sectional" studies have suggested that endocrine therapies such as anastrozole are associated with poorer performance on verbal memory and processing tasks.

For the new study, published in the October edition of The Lancet Oncology, researchers randomly assigned postmenopausal women to receive anastrozole or a placebo daily for five years.

Before the study began, and for six months and 24 months after starting treatment, a subset of 227 of the women underwent tests to measure their cognitive performance, including auditory verbal tasks, logical memory tasks, spatial span tests, and verbal fluency assessments.

There was no difference between the anastrozole or placebo groups at six months or 24 months in changes in attention or memory, or in the number of women who experienced cognitive decline in three or more cognitive tasks.

The only difference between the groups was that at the 24-month time point, significantly more women in the anastrozole group reported experiencing hot flushes.

The authors of the study pointed out that more research is needed to determine the longer-term effects of anastrozole, but said their findings were good news for women who take the medication.

"These findings should be reassuring in the short term for postmenopausal women being treated with anastrozole, their clinicians and carers," they wrote.

This study was part of the International Breast Intervention Study.

More information

The U.S. National Cancer Institute has more about anastrozole.



-- Krisha McCoy



SOURCE: The Lancet Oncology, news release, Sept. 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hospitals provide formula sample packs while medical organizations encourage breastfeeding
2. Komen Travels to Republican Convention to Raise Awareness of Breast Cancer Issues
3. Superbug breast infections controllable in nursing mothers, UT Southwestern researchers find
4. Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues
5. Taking Codeine While Breast-Feeding May Harm Infant
6. Breastfeeding, other factors may affect risk of breast cancer type
7. Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry
8. Risk of Breast Cancer Relapse Can Linger
9. Risk assessment plays key role in long-term treatment of breast cancer
10. MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research
11. Breast-Feeding: The Stress Buster That Lasts for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... PA (PRWEB) , ... March ... ... eastern suburbs and South Hills of Pittsburgh now have easier access to ... Pennsylvania only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Wound care devices and products are used ... The industry mainly consists of establishments engaged in manufacturing ... wounds caused by mechanical, chemical, thermal, and radiogenic trauma; ... diabetes, skin related diseases, immunological diseases, and other chronic ... the largest region in the wound care devices market ...
(Date:3/29/2017)... YORK , March 29, 2017 Global intravenous ... US$ 3 billion by 2021, growing at a CAGR of ... iron prescribed by a doctor to treat anemia or other ... iron level in the body. However, in some cases, oral ... the body and intravenous (IV) iron therapy comes into the ...
(Date:3/29/2017)... 2017  Novartis announced today that the US ... company,s Biologics License Application (BLA) filing and granted ... antigen receptor T cell (CAR-T) therapy, in relapsed ... with B-cell acute lymphoblastic leukemia (ALL). This is ... CAR-T. The priority review designation is expected to ...
Breaking Medicine Technology: